Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Nirosha D. Perera"'
Autor:
Maide Ö. Raeker, Nirosha D. Perera, Athanasios J. Karoukis, Lisheng Chen, Kecia L. Feathers, Robin R. Ali, Debra A. Thompson, Abigail T. Fahim
Publikováno v:
Cells, Vol 13, Iss 12, p 1068 (2024)
Choroideremia is an X-linked chorioretinal dystrophy caused by mutations in CHM, encoding Rab escort protein 1 (REP-1), leading to under-prenylation of Rab GTPases (Rabs). Despite ubiquitous expression of CHM, the phenotype is limited to degeneration
Externí odkaz:
https://doaj.org/article/46723e856b1640f98e5d3ac2dd01bda5
Autor:
Walker M. Schmidt, Nirosha D. Perera, Francis K. Buadi, Suzanne R. Hayman, Shaji K. Kumar, Angela Dispenzieri, David Dingli, Joselle Cook, Martha Q. Lacy, Prashant Kapoor, Nelson Leung, Eli Muchtar, Rahma M. Warsame, Taxiarchis Kourelis, Moritz Binder, Wilson I. Gonsalves, William J. Hogan, Morie A. Gertz
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract Allogeneic stem cell transplant (allo SCT) for multiple myeloma (MM) is potentially curative in some, while toxic in many others. We retrospectively analyzed 85 patients diagnosed with MM who underwent allo SCT as frontline or salvage therap
Externí odkaz:
https://doaj.org/article/6afe9d31036142f29a0a449833c57c66
Autor:
Nirosha D Perera, Tiffany R Bellomo, Walker M Schmidt, Henry K Litt, Margaret Shyu, MaKenna A Stavins, Max M Wang, Alexander Bell, Massoud Saleki, Katherine I Wolf, Ruxandra Ionescu, Jacqueline J Tao, Sunjong Ji, Ryan M O’Keefe, Matthew Pun, Jordan M Takasugi, Jecca R Steinberg, Ronald S Go, Brandon E Turner, Amit Mahipal
Publikováno v:
The Oncologist.
BackgroundFemale underrepresentation in oncology clinical trials can result in outcome disparities. We evaluated female participant representation in US oncology trials by intervention type, cancer site, and funding.Materials and MethodsData were ext
Autor:
Walker M. Schmidt, Nirosha D. Perera, Blake H. Fortes, Benjamin A. Nelson, Wendy M. Smith, Hannah C. Nordhues
Publikováno v:
Cleveland Clinic journal of medicine. 90(1)
Autor:
Nirosha D. Perera, Marija Kamceva, Jolie Z. Shen, Brandon E. Turner, Maya Abdou, Jecca R. Steinberg, Amit Mahipal
Publikováno v:
JAMA network open. 5(7)
Autor:
Nirosha D. Perera, Khalid Jazieh, Size Chen, Jason A. Wampfler, Thanyanan Reungwetwattana, Tucker F. Johnson, Anja Roden, Ping Yang, Dennis A. Wigle, Julian R. Molina
Publikováno v:
Journal of Clinical Oncology. 40:9135-9135
9135 Background: Bronchial carcinoid (BC) is often categorized into multifocal (MBC) or solitary (SBC). MBC, excluding tumorlet and diffuse idiopathic pulmonary neuroendocrine cell hyperplasia, is considered a relatively uncommon subgroup of BC, with
Autor:
Bonnie O. Wong, Nirosha D. Perera, Jolie Z. Shen, Brandon E. Turner, Henry K. Litt, Amit Mahipal, Sherry M. Wren
Publikováno v:
JAMA Network Open
This quality improvement study characterizes surgical oncology trials, analyzes growth, identifies associations with early discontinuation or results reporting, and evaluates proportions of trials involving each neoplasm site.
Autor:
Margaret Shyu, Massoud Saleki, Nirosha D. Perera, Max M. Wang, Nadeen Sarsour, Ryan M O'Keefe, Ruxandra Ionescu, Henry K. Litt, MaKenna A. Stavins, Jecca R. Steinberg, Jordan M. Takasugi, Jacqueline J Tao, Amit Mahipal, Brandon E. Turner, Tiffany R. Bellomo, Sunjong Ji, Roderick King, Matthew Pun, Sayeh Fattahi, Alexander Bell
Publikováno v:
Journal of Clinical Oncology. 39:85-85
85 Background: Females are thought to be underrepresented in clinical trials, which may lead to care disparities. We characterized female enrollment trends in U.S. oncology trials registered on ClinicalTrials.gov and identified features associated wi
Autor:
Margaret Shyu, MaKenna A. Stavins, Alexander Bell, Jolie Z. Shen, Nadeen Sarsour, Ruxandra Ionescu, Nirosha D. Perera, Jacqueline J. Tao, Max M. Wang, Massoud Saleki, Amit Mahipal, Henry K. Litt, Ryan M O'Keefe, Jordan M. Takasugi, Roderick King, Bonnie Wong, Sherry M. Wren, Tiffany R. Bellomo, Jecca R. Steinberg, Brandon E. Turner
Publikováno v:
Journal of Clinical Oncology. 39:1561-1561
1561 Background: Surgical interventions are studied less often than medical or radiation interventions in oncology clinical trials. We characterized surgical oncology trials registered on ClinicalTrials.gov, analyzed funding sources and identified fe